Clinical Trials
3 trialsNCT02834013 2026-06-03
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT06852638 2026-05-12
CD70-targeted immunoPET Imaging of Malignant Cancers
RenJi Hospital
Phase 2 Recruiting
NCT05563272 2025-07-10
STARBURST
Telix Pharmaceuticals (Innovations) Pty Limited
Phase 2 Terminated